Recombinant Human Galectin-9/LGALS9 protein (hFc Tag)

种属

Human

纯度

>90 %, SDS-PAGE

标签

hFc Tag

生物活性

未测试

Cat no : Eg0084

Print datasheet

Synonyms

Galectin 9, LGALS9, Ecalectin, Gal 9, Gal-9



产品信息

纯度 >90 %, SDS-PAGE
内毒素 <0.1 EU/μg protein, LAL method
生物活性 Not tested
来源 HEK293-derived Human Galectin-9 protein Ala2-Thr323 (Accession# O00182-2) with a human IgG1 Fc tag at the N-terminus.
基因ID 3965
蛋白编号 O00182-2
预测分子量 61.8 kDa
SDS-PAGE 68-85 kDa, reducing (R) conditions
组分 Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
复溶 Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
储存条件
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
运输条件 The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

背景信息

The galectins, formerly known as S-type lectins, are a family of β-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Galectin-9 (LGALS9) is a tandem repeat-type member of the galectin family. It has three isoforms (named galectin-9L, galectin-9M, and galectin-9S): long type of 355 amino acids, medium type of 323 amino acids, and short type of 311 amino acids. Galectin-9 is ubiquitously expressed in a variety of tissues, including lymph nodes and spleen, and overexpressed in Hodgkin disease tissue. It is involved in chemoattraction, apoptosis, and the regulation of cell differentiation and has anti-allergic effects. It has been reported that galectin-9 is a ligand for Tim-3, through which galectin-9 can induce T-helper type 1 lymphocyte (Th1) death.

参考文献:

1. Barondes SH. et al. (1994) Cell. 25;76(4):597-8. 2. O Türeci. et al. (1997) J Biol Chem. 272(10):6416-22. 3. Zhang F. et al. (2009) Mol Biol Rep. 36(5):823-30. 4. Zhu C. et al. (2005) Nat Immunol. 6(12):1245-52.